【QH公益直播】澳洲全国中医药针灸学会联合会（FCMA）学术讲座 4 18112 收藏

Theme: Management of Covid-19 with Chinese herbal medicine

主题：中医药对新冠疾病的症状管理

Speakers: Chijing Liu, Sherman Gu, Yuetao Shan, Janet Pai, Max Ma 

主讲人：刘炽京、古旭明、单越涛、王俭、马安阳

Time&Date: 

Sunday 20th March 2022 from 1:00pm-6:00pm (AEDT)

Sunday 20th March 2022 from 10:00am-3:00pm (Beijing Time)

时间：

2022年3月20日 星期天下午1:00-6:00（澳洲东部夏令时)

2022年3月20日 星期天上午10:00-下午3:00（北京时间)

Organiser: FCMA

主办方：澳洲全国中医药针灸学会联合会（FCMA） 

Co-organisers: Chinese Medicine Industry Council of Australia (CMIC); Qihuang Healthcare

协办方：澳大利亚中药行业联合会（CMIC）；QH岐黄网 

Host: FCMA-VIC

承办方：FCMA维州分会

Language: English and Chinese Bilingual

语言：中英双语

Program

讲座流程

Biography of the presenters

演讲者简介

Chijing Liu, graduated from Shandong University of Chinese Medicine in 1983. He also acts as the vice president of Supervisory Board, president of Pulse Group and vice president of Umbilical Acupuncture Group of the World Federation of Chinese Medicine Societies (WFCMS). Dr Liu has significant experience in pulse taking and umbilical acupuncture. Since the Covid-19 outbreak, Dr Liu has helped many patients with Covid or with side effects of Covid vaccination. In this webinar, Dr Liu will discuss his experience and treatment method of managing such patients.

刘炽京，1983年毕业于中国山东中医药大学中医系，现任世界中医药联合会（世界中联）监事会副主席，世界中联脉象研究专业委员会会长，世界中联易医脐针常务副会长兼秘书长，主要从事脉象与脐针的临床与研究工作。自新冠病毒爆发全球流行以来，他接诊了大量新冠以及新冠疫苗副作用的患者。本次讲座，刘医生将讲解他应用中医药管理新冠病毒的一系列症状及常见新冠疫苗副作用的经验和思路。

Sherman Gu, graduated from Guangzhou University of Chinese Medicine in 1982. He has been involved in clinical practice, education and research in Chinese medicine since. Dr Gu completed his postgraduate studies with awards of Master of Applied Science and PhD at the RMIT University where he received strict training in Evidence-based Medicine (EBM) methodology including systematic review with meta-analysis, medical statistic, design, implementation and reporting of randomised controlled trials (RCT). He has published papers and research letters in top medical journals such as Cochrane Collaboration, JAMA and British Journal of Dermatology. Dr Gu has devoted to evaluation of effect of Chinese medicine with method of EBM for years. In this webinar, Sherman will report methods and findings of Chinese herbal medicine (CHM) for COVID-19 from a systematic review and meta-analysis conducted by his team. The findings provide preliminary EBM evidence to support the clinical application of CHMs for the condition.

古旭明博士1982年毕业于广州中医药大学。毕业后从事中医临床，教学和科研工作。古博士在皇家墨尔本理工大学攻读硕士和博士学位期间接受了系统评估及荟萃分析，医学统计分析和随机对照临床试验设计，实施和报告等循证医学方法学的严格培养。他以第一作者分别在《考科伦协作网》，《美国医学会杂志》，《英国皮肤科杂志》等顶尖医学期刊上发表多篇论文和信函。多年来他致力于使用循证医学方法评估中医临床疗效。本次讲座，古博士将介绍他和团队其他成员合作完成的有关中医药治疗新冠疾病的系统评估和荟萃分析方法和成果，从而为运用中医药治疗新冠疾病提供初步的循证医学依据。

Yuetao Shan, was born in a Chinese medicine family and graduated from the Fujian University of Chinese medicine. She has been practiced Chinese medicine in China, New Zealand and Australia since 1992 and gains extensive experience. Dr. Shan also acts as the vice president of Pulse group of the World Federation of Chinese Medicine Societies. In this webinar, Dr Shan will share her experience in management of Omicron variant infection cases with Chinese herbal medicine.

单越涛，出身中医世家，毕业于福建中医药大学。现任世界中联脉象专业委员会副会长兼副秘书长。单医生具有二十多年的临床实践经验。本次讲座，单医生将分享她如何应用中医药治疗感染新冠病毒奥米克隆变异株病例体会。

Janet Pai, graduated from Nanjing University of Chinese medicine with a Master degree in 2003. She is a registered Chinese medicine practitioner and acupuncturist in Australia.Dr.Wang has significant experience in applying Chang Sang Jun’s Pulse method in the Chinese medicine syndrome diagnosis and treatment. In this webinar, Dr Wang will share her experience of management of post Covid-19 conditions with Chinese herbal medicine.

王俭，2003年毕业于南京中医药大学本硕连读专业。2004年来澳后成为注册中医师和针灸师执业至今。在近20年的临床实践中积累了丰富的临床经验。本次讲座，王医生将分享她的几个帮助新冠患者缓解后遗症的医案。

Max Ma, owns a Master's Degree in Herbal Medicine and Doctoral Degree in Medicine, is the founding member and executive director of Beijing Tong Ren Tang Australia.Dr.Ma has more than 35 years of experience in Chinese medicine, and acts as an External Advisory Committee Member for both of the Traditional Chinese Medicine Programs of Western Sydney University and University of Technology Sydney, and a committee member of the Australian Mirror Committee of the Chinese medicine standardization committee (HE031) under the International Standard Organization (ISO/TC249), as well as the member of the Reference Group of the Chinese Medicine Board of Australia (CMBA). He is the president of the Chinese Medicine Industry Council of Australia (CMIC).In this webinar, Dr Ma will conduct a discussion on the safety of Chinese herbal medicine and its assessing issues in Australia.

马安阳，植物药硕士，医学博士。北京同仁堂澳大利亚有限公司创始成员，执行董事。马博士从事中医药超过35年, 是西悉尼大学和悉尼科技大学中医课程外部顾问组成员，国际标准组织中医药标准化专家委员会（ISO/TC249）澳洲技术委员会（HE031）理事，澳大利亚中医管理局（CMBA）顾问组成员。澳大利亚中药行业联合会（CMIC）会長。本次讲座，马博士将与大家讨论澳洲中药安全性及其评估标准的问题。

获取更多中医名家的讲座，请扫下方二维码关注QH岐黄网公众号，或微信搜索：QH岐黄网

观看如有任何疑问，请联系客服：

QH客服1：QH小助手（微信号：QHACU01）

QH客服2：Facebook：Qihuang Healthcare (点击进入)

QH客服3：邮箱：qihuanghealthcare@gmail.com

以上内容由专业中医师提供（演示），仅供参考，建议在专业医师指导下学习。我们不对任何人进行模仿学习时引发的任何不良后果负责。

如有任何疑问，欢迎在直播间“聊天室”留言、咨询，语言不限于中英文、粤语。

本次直播的最终解释权归广州岐黄信息科技有限公司所有。